Evidence map›Paper›PMID 39078113›Full record

ArticleBioinformatics (Oxford, England)2024

RawHash2: mapping raw nanopore signals using hash-based seeding and adaptive quantization.

Can Firtina, Melina Soysal, Joël Lindegger, Onur Mutlu

Abstract read
In one paragraph

Article in Bioinformatics (Oxford, England), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Can FirtinaDepartment of Information Technology and Electrical Engineering, ETH Zurich, Zurich 8092, Switzerland.ORCID 0000-0002-6548-7863
Melina SoysalDepartment of Information Technology and Electrical Engineering, ETH Zurich, Zurich 8092, Switzerland.ORCID 0009-0000-2378-6737
Joël LindeggerDepartment of Information Technology and Electrical Engineering, ETH Zurich, Zurich 8092, Switzerland.ORCID 0000-0003-2581-8637
Onur MutluDepartment of Information Technology and Electrical Engineering, ETH Zurich, Zurich 8092, Switzerland.ORCID 0000-0002-0075-2312

Funding

European Union's Horizon Programme for Research and InnovationSemiconductor Research CorporationSwiss National Science Foundation 200021_213084
6 · The paper itself

Abstract

summaryRaw nanopore signals can be analyzed while they are being generated, a process known as real-time analysis. Real-time analysis of raw signals is essential to utilize the unique features that nanopore sequencing provides, enabling the early stopping of the sequencing of a read or the entire sequencing run based on the analysis. The state-of-the-art mechanism, RawHash, offers the first hash-based efficient and accurate similarity identification between raw signals and a reference genome by quickly matching their hash values. In this work, we introduce RawHash2, which provides major improvements over RawHash, including more sensitive quantization and chaining algorithms, weighted mapping decisions, frequency filters to reduce ambiguous seed hits, minimizers for hash-based sketching, and support for the R10.4 flow cell version and POD5 and SLOW5 file formats. Compared to RawHash, RawHash2 provides better F1 accuracy (on average by 10.57% and up to 20.25%) and better throughput (on average by 4.0× and up to 9.9×) than RawHash. AVAILABILITY AND IMPLEMENTATION: RawHash2 is available at https://github.com/CMU-SAFARI/RawHash. We also provide the scripts to fully reproduce our results on our GitHub page.

Indexed as

AlgorithmsSoftwareHigh-Throughput Nucleotide SequencingHumansNanoporesNanopore SequencingSequence Analysis, DNA

Identifiers

PMID39078113
PMCPMC11333567

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.